One important way is inducing tumor angiogenesis, increasing their VEGF secretion and resulting in the formation of neo‐angiogenic cells, therefore, several anti‐vascular endothelial growth factor (VEGF) and VGFR inhibitors have been explored for the therapy on GC.53 The gene discussed is VEGFA; the disease is gastric cancer.